Cardiopulmonary Bypass Equipment - Global Market Insights, Competitive Landscape, and Market Forecast - 2028

Cardiopulmonary Bypass Equipment - Global Market Insights, Competitive Landscape, and Market Forecast - 2028

Cardiopulmonary Bypass Equipment Market By Product (Heart–Lung Machines, Oxygenators, Autotransfusion Systems, and Others), Application (Cardiovascular, Respiratory, Hemodialysis, and Others), End-User (Hospitals, Specialty Clinics, Dialysis Centers, and Ambulatory Surgery Centers), and Geography is expected to grow at a steady CAGR Forecast till 2028 owing to increasing prevalence of cardiovascular diseases and rising geriatric population

The global cardiopulmonary bypass equipment market was valued at USD 405.18 million in 2022, growing at a CAGR of 4.14% during the forecast period from 2023 to 2028, to reach USD 516.82 million by 2028. The demand for cardiopulmonary bypass equipment is primarily motivated by the increase in the prevalence of cardiovascular diseases like atrial fibrillation, atrial flutter, and supraventricular tachycardia, decrease in heart muscle elasticity, decrease in heart output, rising burden of the geriatric population, increasing technological advancements and surge in product development activities among others during the forecast period.

Cardiopulmonary Bypass Equipment Market Dynamics:

According to World Health Organization (2022), approximately 17.9 million people die from cardiovascular diseases, which is an estimated 31% of all deaths worldwide. By 2030, around 23.6 million people are expected to die due to cardiovascular disorders. Thus, the number of surgeries for cardiovascular diseases is increasing, requiring cardiopulmonary bypass (CPB), which provides a bloodless field for cardiac surgery. The advancement in cardiac surgery has been possible due to the development of cardiopulmonary bypass.

As per the recent survey, Global Population Aging 2020 Report (United Nations, 2020), the aging population tends to grow at an alarming pace. In 2020, there were around 727 million individuals in the world aged 65 years or older. By 2050, the figure of such patients is expected to double and reach 1.5 billion by 2050. With increasing age, the risk for cardiovascular diseases and the need for cardiac surgeries also increases and will thereby assist in the growth of cardiopulmonary bypass equipment.

Moreover, companies are increasing their research and development to develop products that have better efficacy and are easy to operate. For example, in October 2020, Abiomed announced that its compact cardiopulmonary bypass system, Breethe OXY-1, received 510(k) clearance from the FDA.

Thus, all these factors are projected to drive the growth of the market for cardiopulmonary bypass equipment.

Certain factors such as the high cost of cardiac surgery and risk of failure during the surgery and strict regulations by regulatory bodies pose a minor hurdle to the growth of the market.

Cardiopulmonary Bypass Equipment Market Segment Analysis:

Cardiopulmonary Bypass Equipment Market By Product (Heart–Lung Machines, Oxygenators, Autotransfusion Systems, and Others), Application (Cardiovascular, Respiratory, Hemodialysis, and Others), End-User (Hospitals, Specialty Clinics, Dialysis Centers, and Ambulatory Surgery Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product type of devices segment, heart–lung machines are expected to hold the largest share in the market as cardiopulmonary bypass equipment. This is attributed to the advantages and applications associated with heart-lung machines.

Heart-Lung Machines are an important tool required during any cardiopulmonary surgery. An artificial heart-lung machine is used in open-heart surgeries to support the proper functioning of the heart and body during the surgery.

The heart-lung machine consists of a chamber that receives blood from the body, oxygenates the blood, and transfers it to all parts of the body. This machine is connected to the patient with a series of tubes, which are removed after the completion of the surgery when the heart and lungs resume their functions.

The increase in the prevalence of heart disease, a growing aging population who are very susceptible to coronary heart disease and pulmonary diseases, technological developments in artificially managing the organs that minimize the burden on the heart and lungs during surgery, and improved efficiency of devices are some of the other factors assisting in the growing demand for heart-lung machines.

Additionally, assistance from government bodies, in equipping new/existing hospitals and healthcare centers in rural regions, is expected to enhance the market potential in several countries.

Hence, all the above-mentioned factors are expected to drive the segment growth.

North America is expected to dominate the overall Cardiopulmonary Bypass Equipment Market:

North America is expected to dominate the overall cardiopulmonary bypass equipment market during the forecast period. This domination is due to the growing number of individuals with cardiopulmonary and other chronic diseases, changing lifestyles, rising geriatric population, presence of key players, increasing product development activities in the region, and others during the forecast period.

The Centers for Disease Control and Prevention (CDC) 2022, estimated that about 20.1 million adults aged 20 and older had Coronary artery disease (CAD) in the US, in 2020.

Also, the same source stated that in the United States, someone has a heart attack every 40 seconds. Every year, about 805,000 people in the United States have a heart attack. Out of these, 605,000 are a first heart attack, 200,000 happen to people who have already had a heart attack and about 1 in 5 heart attacks are silent—the damage is done, but the person is not aware of it.

This situation is giving rise to a critical need for cardiopulmonary bypass equipment for the diagnosis, prevention, and treatment of the disease.

The increasing number of product development activities in the region is further going to accelerate the growth of the cardiopulmonary bypass equipment market. For example, in March 2023 the US Food and Drug Administration (FDA) granted 510(k) clearance to LivaNova’s Essenz heart-lung machine (HLM) for use in cardiopulmonary bypass (CPB) procedures.

Cardiopulmonary Bypass Equipment Key Players:

Some of the key market players operating in the cardiopulmonary bypass equipment market include Medtronic PLC, LivaNova PLC, MAQUET Holding B.V. & Co. KG., Terumo Corporation, Braile Biomedica Ltda, Tianjin Medical, Senko Medical Instrument Manufacturing Co. Ltd., and others.

Recent Developmental Activities in Cardiopulmonary Bypass Equipment:

In August 2022, FDA awarded the breakthrough privileges to Abiomed's Impella ECP expandable percutaneous heart pump.

In April 2022, LivaNova received FDA 510(k) clearance for its B-Capta system integrated into the S5 heart-lung machine.

In October 2020, Abiomed received FDA 510(k) clearance for an all-in-one, compact extracorporeal membrane oxygenation (ECMO) cardiopulmonary bypass system called the Abiomed Breethe OXY-1 System.

Key Takes Away from the Cardiopulmonary Bypass Equipment Market Report Study

Market size analysis for current market size (2022), and market forecast for 5 years (2023-2028)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global cardiopulmonary bypass equipment market.

Various opportunities available for the other competitor in the cardiopulmonary bypass equipment market space.

What are the top-performing segments in 2022? How these segments will perform in 2028?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for market growth in the coming future?

Target Audience who can be benefited from this Cardiopulmonary Bypass Equipment Market Report Study

Cardiopulmonary Bypass Equipment providers

Research organizations and consulting companies

Cardiopulmonary Bypass Equipment-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders

Various End-users who want to know more about the cardiopulmonary bypass equipment market and the latest technological developments in the cardiopulmonary bypass equipment market.

Frequently Asked Questions for Cardiopulmonary Bypass Equipment Market:

1. What is Cardiopulmonary Bypass Equipment?

Cardiopulmonary bypass (CPB) equipment provides a bloodless field for cardiac surgery and does the work of both the heart (i.e., pumps blood) and the lungs (i.e., oxygenates the blood). CPB circuit includes pumps, cannulae, tubing, reservoir, oxygenator, heat exchanger, and arterial line filter. Cardiopulmonary bypass machines are operated by perfusionists to bypass the heart and lungs during open-heart surgery.

2. What is the market for global cardiopulmonary bypass equipment?

The global cardiopulmonary bypass equipment market was valued at USD 405.18 million in 2022, growing at a CAGR of 4.14% during the forecast period from 2023 to 2028, to reach USD 516.82 million by 2028.

3. What are the drivers for the cardiopulmonary bypass equipment market?

The major drivers driving the demand for cardiopulmonary bypass equipment are the increase in the prevalence of cardiovascular diseases like atrial fibrillation, atrial flutter and supraventricular tachycardia, a decrease in heart muscle elasticity, a rising geriatric population, increasing technological advancements, and a surge in product development activities among others.

4. Who are the key players operating in the global cardiopulmonary bypass equipment market?

Some of the key market players operating in the cardiopulmonary bypass equipment market include Medtronic PLC, LivaNova PLC, MAQUET Holding B.V. & Co. KG., Terumo Corporation, Braile Biomedica Ltda, Tianjin Medical, Senko Medical Instrument Manufacturing Co. Ltd., and others.

5. Which region has the highest share in the cardiopulmonary bypass equipment market?

North America is expected to dominate the overall cardiopulmonary bypass equipment market during the forecast period, 2023 to 2028. This domination is due to the growing number of cardiac surgeries, demand for advanced technologies in cardiopulmonary bypass equipment, and rise in healthcare expenditure by the US government among others.



Please Note: It will take 3-5 business days to complete the report upon order confirmation.